Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen

E. Van Cutsem, J. Tabernero, R. Lakomy, H. Prenen, J. Prausová, T. Macarulla, P. Ruff, Guy Van Hazel, V. Moiseyenko, D. Ferry, J. Mckendrick, J. Polikoff, A. Tellier, R. Castan, C. Allegra

    Research output: Contribution to journalArticlepeer-review

    977 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)3499-3506
    JournalJournal of Clinical Oncology
    Publication statusPublished - 2012

    Cite this